Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Firefly Neuroscience (AIFF) Return on Capital Employed (2016 - 2025)

Firefly Neuroscience has reported Return on Capital Employed over the past 13 years, most recently at 1.03% for Q4 2025.

  • Quarterly results put Return on Capital Employed at 1.03% for Q4 2025, down 50373.0% from a year ago — trailing twelve months through Dec 2025 was 1.03% (down 50373.0% YoY), and the annual figure for FY2025 was 1.88%, down 930.0%.
  • Return on Capital Employed for Q4 2025 was 1.03% at Firefly Neuroscience, down from 0.89% in the prior quarter.
  • Over the last five years, Return on Capital Employed for AIFF hit a ceiling of 502.7% in Q4 2024 and a floor of 8.46% in Q1 2025.
  • Median Return on Capital Employed over the past 5 years was 0.49% (2024), compared with a mean of 24.11%.
  • Biggest five-year swings in Return on Capital Employed: skyrocketed 50292bps in 2024 and later crashed -50373bps in 2025.
  • Firefly Neuroscience's Return on Capital Employed stood at 0.01% in 2021, then crashed by -12834bps to 0.64% in 2022, then surged by 66bps to 0.22% in 2023, then soared by 226178bps to 502.7% in 2024, then plummeted by -100bps to 1.03% in 2025.
  • The last three reported values for Return on Capital Employed were 1.03% (Q4 2025), 0.89% (Q3 2025), and 1.05% (Q2 2025) per Business Quant data.